MedTrace Logo

Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus

NCT03932851 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-05-01

No results posted yet for this study

Summary

This study is intended to retrospectively collect HBV-infected pregnant women and non-HBV-infected pregnant women who have been born in IVF in the investigators' hospital, collect pregnant women's data during pregnancy, newborn birth data, and hepatitis B virus in July after birth of newborns born to HBV-infected pregnant women. Infection, explore the impact of HBV infection on IVF outcomes and whether IVF operations increase the risk of mother-to-child transmission of HBV.

Conditions

  • Pregnancy

Interventions

OTHER

IVF-ET

HBV-infected pregnant women and non-HBV-infected pregnant women underwent IVF operation

Sponsors & Collaborators

  • Beijing Ditan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-05-01
Completion
2019-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932851 on ClinicalTrials.gov